Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
HPK1 ANTAGONISTS AND USES THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/193759
Kind Code:
A1
Abstract:
Described herein are HPK1inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of a disease or disorder associated with HPK1.

More Like This:
WO/2017/0875282-SUBSTITUTED QUINAZOLINE COMPOUNDS COMPRISING A SUBSTITUTED HETEROCYCLIC GROUP AND METHODS OF USE THEREOF
WO/2021/069927PROSTAGLANDIN EP4 RECEPTOR ANTAGONIST COMPOUNDS
WO/2022/167457GPR84 ANTAGONISTS AND USES THEREOF
Inventors:
DING XIAO (CN)
DING XIAOYU (CN)
LIU YINGTAO (CN)
LU HONGFU (CN)
PENG JINGJING (CN)
REN FENG (CN)
Application Number:
PCT/CN2023/086571
Publication Date:
October 12, 2023
Filing Date:
April 06, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
INSILICO MEDICINE IP LTD (CN)
International Classes:
C07D471/04; A61K31/502; A61K31/517; A61P35/00; C07D217/12; C07D237/26; C07D403/14; C07D519/00
Domestic Patent References:
WO2022174253A12022-08-18
WO2021050964A12021-03-18
Foreign References:
CN116023378A2023-04-28
CN110678466A2020-01-10
US20190256520A12019-08-22
CN101990539A2011-03-23
CN102977125A2013-03-20
CN103384669A2013-11-06
Attorney, Agent or Firm:
AFD CHINA INTELLECTUAL PROPERTY LAW OFFICE (CN)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: COMMUNICATION METHOD AND COMMUNICATION APPARATUS

Next Patent: COMPOUNDS AND METHODS OF TREATING CANCERS